AVBCC Value-Based Voices
by Rachael
Latest episode
Medicare Advantage, AI, MFN, China, and Consensus Building: Powerful…
Medicare Advantage, AI, MFN, China, and Consensus Building: Powerful…
About this podcast
The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving
landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.
Episodes
- Medicare Advantage, AI, MFN, China, and Consensus Building: Powerful Insights from HLC · 40 min · Season 1 Episode 18Value-Based Voices welcomes Maria Ghazal, JD, MA, President & CEO, Healthcare Leadership Council, for a dynamic conversation spanning Medicare Advantage, prior authorization…
- Who Gets Access? Understanding the New Reality of Cancer Drug Coverage · 28 min · Season 1 Episode 17Are oncology treatments losing their "special status" with payers? In this episode of Value-Based Voices, host Brian Reid, MS, Principal of Reid Strategic and author of the Cost…
- AI at the Point of Care: Inside OpenEvidence's Approach to Smarter Clinical Decisions · 41 minArtificial intelligence is rapidly reshaping healthcare, but what does that look like in the day-to-day practice of oncology? In this episode of AVBCC's Value-Based Voices, host…
- Red Tape: Real Consequences for Patients with Cancer · 42 minWhat happens when patients with cancer spend weeks navigating insurance requirements before receiving physician-prescribed care? In our latest episode of Value-Based Voices…
- Part D Upheaval: Why the Cancer Community Needs to Pay Attention · 47 min · Season 1 Episode 13In this episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sits down with Joel White, Partner and Head of…
- Can the U.S. Keep Its Edge? FDA Policy, China’s Momentum, and the Future of Innovation · 38 min · Season 1 Episode 12In this follow up conversation, Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies and AVBCC Board Members, and Steve Usdin, Senior Editor, Washington, BioCentury…
- The Future of the FDA: What Comes Next? · 26 min · Season 1 Episode 11In this first of a 2-part series featuring Steve Usdin, Senior Editor, Washington, BioCentury Publications, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies and…
- Reflections on the NCCN · 24 min · Season 1 Episode 10In this episode of Value-Based Voices, we delve into the mission and inner workings of the NCCN, a cornerstone organization shaping cancer treatment standards in the U.S. and…
- Advancing Cancer Research and Innovation through Collaboration at GCRIS 2026 · 33 minWe're taking a deep dive into the upcoming Global Cancer Research and Innovation Symposium (GCRIS) in this latest episode of Value-Based Voices. Join GCRIS Scientific Co-chairs…
- Breaking the Model: Can Value-Based Insurance Deliver? · 32 min · Season 1 Episode 8Most cancer drugs today are more effective and accessible than ever—yet patients often face crushing costs because our healthcare system still values profit over patient benefit…
- From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology · 22 min · Season 1 Episode 7Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door to tailored cancer…
- Navigating Value and Policy in U.S. Cancer Care and Pharma Pricing · 35 min · Season 1 Episode 6International reference pricing could drastically reshape drug costs in the U.S. and threaten domestic innovation. In this latest episode of AVBCC’s Value-Based Voices, join…
- Most Favored Nation and What's Next · 34 minMost companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America? In this episode of…
- AI Revolution: Breaking Pharmacy Chains with Harry Travis, BS Pharm, MBA, and Ira Klein, MD, MBA, FACP · 22 min · Season 1 Episode 4There are countless opportunities hidden in the data-driven tasks pharmacists do every day, and AI is ready to unlock them. But what happens when automation dramatically…
- Consolidation Versus Independence in Cancer Care · 25 min · Season 1 Episode 3Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits? In this episode of Value-Based Voices Sarah Alwardt, PhD, President…
- Insights from JP Morgan 2026 with Liz Fowler, PhD, JD · 25 min · Season 1 Episode 1Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized…
- More Insights from JP Morgan 2026 with Jeff Berkowitz, JD · 39 min · Season 1 Episode 2Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its…







